Tower Research Capital (TRC)’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,474
| Closed | -$644K | – | 6900 |
|
|
2022
Q3 | $644K | Buy |
12,474
+1,616
| +15% | +$66.8K | 0.01% | 944 |
|
|
2022
Q2 | $269K | Buy |
10,858
+2,582
| +31% | +$56.9K | 0.01% | 1558 |
|
|
2022
Q1 | $208K | Sell |
8,276
-6,042
| -42% | -$170K | ﹤0.01% | 1695 |
|
|
2021
Q4 | $521K | Buy |
14,318
+1,926
| +16% | +$67.6K | 0.01% | 1086 |
|
|
2021
Q3 | $211K | Buy |
12,392
+7,317
| +144% | +$114K | 0.01% | 1777 |
|
|
2021
Q2 | $68K | Buy |
5,075
+1,509
| +42% | +$37.2K | ﹤0.01% | 2768 |
|
|
2021
Q1 | $183K | Buy |
3,566
+2,225
| +166% | +$134K | ﹤0.01% | 2090 |
|
|
2020
Q4 | $83K | Sell |
1,341
-565
| -30% | -$32.3K | ﹤0.01% | 2538 |
|
|
2020
Q3 | $104K | Sell |
1,906
-5,815
| -75% | -$313K | ﹤0.01% | 3121 |
|
|
2020
Q2 | $444K | Buy |
+7,721
| New | +$420K | 0.02% | 1132 |
|
|
2020
Q1 | – | Sell |
-4,993
| Closed | -$197K | – | 4219 |
|
|
2019
Q4 | $197K | Buy |
4,993
+3,548
| +246% | +$62.3K | 0.02% | 596 |
|
|
2019
Q3 | $9K | Sell |
1,445
-1,661
| -53% | -$12.5K | ﹤0.01% | 3027 |
|
|
2019
Q2 | $29K | Buy |
+3,106
| New | +$36K | ﹤0.01% | 1934 |
|
|
2019
Q1 | – | Sell |
-257
| Closed | -$3K | – | 4495 |
|
|
2018
Q4 | $3K | Sell |
257
-369
| -59% | -$3.89K | ﹤0.01% | 3261 |
|
|
2018
Q3 | $8K | Sell |
626
-6,167
| -91% | -$74.3K | ﹤0.01% | 2921 |
|
|
2018
Q2 | $89K | Buy |
6,793
+4,831
| +246% | +$57.8K | 0.01% | 1510 |
|
|
2018
Q1 | $27K | Sell |
1,962
-4,145
| -68% | -$42.8K | ﹤0.01% | 2026 |
|
|
2017
Q4 | $36K | Buy |
6,107
+1,646
| +37% | +$11.3K | ﹤0.01% | 1594 |
|
|
2017
Q3 | $33K | Buy |
+4,461
| New | +$37.1K | ﹤0.01% | 2371 |
|
|
2017
Q1 | – | Sell |
-3,358
| Closed | -$25K | – | 4161 |
|
|
2016
Q4 | $25K | Buy |
+3,358
| New | +$24.2K | ﹤0.01% | 1950 |
|
|
2016
Q3 | – | Sell |
-753
| Closed | -$3K | – | 4718 |
|
|
2016
Q2 | $3K | Buy |
+753
| New | +$2.83K | ﹤0.01% | 3772 |
|
|
2016
Q1 | – | Sell |
-200
| Closed | -$2K | – | 5188 |
|
|
2015
Q4 | $2K | Buy |
+200
| New | +$1.42K | ﹤0.01% | 3857 |
|
|
2015
Q3 | – | Sell |
-100
| Closed | -$1K | – | 5020 |
|
|
2015
Q2 | $1K | Sell |
100
-781
| -89% | -$6.2K | ﹤0.01% | 4123 |
|
|
2015
Q1 | $7K | Buy |
+881
| New | +$6.88K | ﹤0.01% | 3087 |
|
|
2014
Q4 | – | Sell |
-6,278
| Closed | -$28K | – | 4898 |
|
|
2014
Q3 | $28K | Buy |
+6,278
| New | +$33.2K | ﹤0.01% | 2038 |
|
|
2014
Q2 | – | Sell |
-247
| Closed | -$1K | – | 4798 |
|
|
2014
Q1 | $1K | Sell |
247
-1,905
| -89% | -$13.2K | ﹤0.01% | 4242 |
|
|
2013
Q4 | $12K | Buy |
2,152
+1,714
| +391% | +$8.84K | ﹤0.01% | 2849 |
|
|
2013
Q3 | $2K | Buy |
+438
| New | +$4.74K | ﹤0.01% | 4169 |
|
Other funds holding CCXI
Tower Research Capital (TRC)'s CCXI Position: Q4 2022 in Review
Tower Research Capital (TRC) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 12,474 shares — an estimated $644K sold.
Tower Research Capital (TRC) first reported a position in CCXI in Q3 2013 and held it in 28 quarters. The position peaked at $644K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Tower Research Capital (TRC) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 12,474 ChemoCentryx, Inc. shares in Q4 2022, an estimated $644K.
- Tower Research Capital (TRC) first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 28 quarters.
- Tower Research Capital (TRC)'s ChemoCentryx, Inc. position peaked at $644K in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.